TrialClinical rheumatology2026

Ivarmacitinib in patients with active ankylosing spondylitis: subgroup analysis based on key baseline features from a phase II/III trial.

Bei Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.